HEMOLYTIC-ANEMIA FOLLOWING SUCCIMER ADMINISTRATION IN A GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENT PATIENT

被引：12

作者：

GERR, F ^{[1
]}

FRUMKIN, H ^{[1
]}

HODGINS, P ^{[1
]}

机构：

[1] EMORY CLIN,ATLANTA,GA

来源：

JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY | 1994年 / 32卷 / 05期

关键词：

DIMERCAPTOSUCCINIC ACID; HEMOLYTIC ANEMIA; LEAD TOXICITY; HUMAN;

D O I：

10.3109/15563659409011061

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

Because of its favorable side effects profile, the oral chelating agent dimercaptosuccinic acid is often used for treatment of lead intoxication. We report a case of a 45-year-old black male with glucose-6-phosphate dehydrogenase deficiency and a 17 year history of occupational lead exposure who developed hemolysis during treatment with dimercaptosuccinic acid for symptomatic lead intoxication.

引用

页码：569 / 575

页数：7

共 24 条

[1] [Anonymous], 1988, NATURE EXTENT LEAD P
[2] [Anonymous], 1989, B WORLD HEALTH ORGAN
[3] APOSHIAN HV, 1990, ANNU REV PHARMACOL, V30, P279
[4] BEUTLER E, 1979, HEMOLYTIC ANEMIA DIS
[5] CORYSLECHTA DA, 1988, J PHARMACOL EXP THER, V246, P84
[6] ADULT INORGANIC LEAD-INTOXICATION - PRESENTATION OF 31 NEW CASES AND A REVIEW OF RECENT ADVANCES IN THE LITERATURE
CULLEN, MR
ROBINS, JM
ESKENAZI, B
[J]. MEDICINE, 1983, 62 (04) : 221 - 247
[7] DHAWAN M, 1989, BIOCHEM INT, V19, P1067
[8] CHRONIC LEAD NEPHROPATHY - DIAGNOSTIC USE OF CALCIUM EDTA AND ASSOCIARION WITH GOUT
EMMERSON, BT
[J]. AUSTRALASIAN ANNALS OF MEDICINE, 1963, 12 (04): : 310 - +
[9] ENG KH, 1982, 10TH P AS C OCC HLTH, P481
[10] 2,3-DIMERCAPTOSUCCINIC ACID TREATMENT OF HEAVY-METAL POISONING IN HUMANS
FOURNIER, L
THOMAS, G
GARNIER, R
BUISINE, A
HOUZE, P
PRADIER, F
DALLY, S
[J]. MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1988, 3 (06): : 499 - 504

← 1 2 3 →